Single MVA-SARS-2-ST/N vaccination rapidly protects K18-hACE2 mice against a lethal SARS-CoV-2 challenge infection

S Clever, L Limpinsel, C Meyer zu Natrup… - Viruses, 2024 - mdpi.com
The sudden emergence of SARS-CoV-2 demonstrates the need for new vaccines that
rapidly protect in the case of an emergency. In this study, we developed a recombinant MVA …